UNLEASH IMMUNO ONCOLYTICS

Unleash IO develops oncolytic immunotherapy products shown to be highly specific and efficacious in animal models and human tissue samples. Unleash IO’s leading product, UIO-512, is an oncolytic adenovirus that targets both malignant cells and tumor-associated stroma cells. UIO-512 is armed with GM-CSF, a potent immune-modulatory cytokine, triggering an immune response towards the tumor. UIO-512 lead indication is in ovarian cancer, follow on indications include other solid tumors such as glio... blastoma, melanoma and pancreatic cancer. Promising pre-clinical results in animal models and fresh human samples of ovarian cancers as well as in melanoma were published in top ranked peer-reviewed publications. Unleash IO is raising $3.5 M to conduct a phase I/II clinical trial in ovarian cancer with oncolytic immunotherapy UIO-512.

#SimilarOrganizations #People #Financial #Website #More

UNLEASH IMMUNO ONCOLYTICS

Social Links:

Facebook

Linkedin

Twitter

Industry:

Biotechnology Medical Device Therapeutics

Founded:

2015-01-01

Address:

Saint Louis, Missouri, United States

Country:

United States

Website Url:

http://www.unleash.bio

Total Employee:

1+

Status:

Active

Contact:

314-730-0050

Email Addresses:

[email protected]

Total Funding:

3 M USD

Technology used in webpage:

SPF Google Apps For Business Hostgator Mail Oracle Cloud A2 Hosting

Similar Organizations

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

Current Employees Featured

ariel-muslera_image

Ariel Muslera
Ariel Muslera CFO @ Unleash Immuno Oncolytics
CFO

daniel-katzman_image

Daniel Katzman
Daniel Katzman CEO @ Unleash Immuno Oncolytics
CEO
2015-01-01

david-t-curiel_image

David T. Curiel
David T. Curiel CSO @ Unleash Immuno Oncolytics
CSO

Founder

david-t-curiel_image

David T. Curiel

Investors List

oncolys-biopharma-inc_image

Oncolys BioPharma

Oncolys BioPharma investment in Venture Round - Unleash Immuno Oncolytics

skandalaris-center-for-interdisciplinary-innovation-and-entrepreneurship_image

Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship

Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship investment in Grant - Unleash Immuno Oncolytics

Official Site Inspections

http://www.unleash.bio Semrush global rank: 5.33 M Semrush visits lastest month: 1.56 K

Host Informations
Whois Informations

Loading ...

More informations about "Unleash Immuno Oncolytics" on Search Engine